Conference Series has been organizing International Conference on BA/BE Studies in consecutive years at America, over the last several years which met with great achievement in Business Conferencing and it has marked its Business very excited to expand Europe and Asia Pacific continents. Previous meetings were held in major cities like Baltimore, Chicago, Atlanta and Hyderabad. It’s time to announce “9th World Congress on BA/BE Studies and Biowaivers” held July 17-19, 2017 at Melbourne, Australia. Bioequivalence Congress is a 3-day event offering the Exhibition, at venue to showcase the research and development on emerging technologies and have wider sessions involving Keynote presentation, Oral, YRF ( student presentation), poster, e-poster presentations. This is an excellent platform to intensify collaborations for Professionals Scientific Experts and Industrial Delegates for Pharma field knowledge seekers.


The global generic drugs market 2016 report forecasts patent expiry of drugs worth $150 billion by 2020, which a key growth driver for top-selling drugs as well as new, inexpensive generic drugs. Patent expiry of a branded drug results in the introduction of inexpensive generic drugs in the market. Branded drugs with sales of up to $135 billion expired by the end of 2015, offering pharmaceutical companies opportunities to capitalize on this market. The Australian pharmaceuticals industry comprises bio-medical research, biotechnology firms, originator and generic medicines companies and service-related segments including wholesaling and distribution. This sector is expected to reach $300.9 billion in 2013 and $518.5 billion in 2018, with a compound annual growth rate (CAGR) of 11.5%.


Everyone interested in the future of emerging –drugs majorly in the field drug discovery, design, drug development, pharmacokinetic research, clinical pharmacology and new therapeutic drugs on recent developments in the field of generic drug research, current challenges and possibilities in modeling a new drug involving bioavailability and bioequivalence research.

Who to attend:

CEOs, CROs, Directors, Managers and research associates in pharmaceutical industry in the drug or device industries (both innovator and generic)
Academic and Industrial Scientists Associated with Discovery, Formulation and The Delivery of Drugs
Regulatory and Clinical Scientists involved in Drug Development
Researchers, Education providers in Clinical Pharmacy, Pharmacology and Toxicology
Students and Postdoctoral Fellows in All Areas of The Pharmaceutical Sciences
Government Agencies involved in Chemical Safety Assessment
Medical Practitioners Such As Clinical Pharmacologists, Clinical Toxicologists.
Molecular and Cellular Pharmacologists

Why to attend??

• Exchange ideas and network with leading pharmaceutical scientists and clinicians and presenting cutting-edge discoveries, research and new therapeutic drugs
• Obtain a global roundup of Pharmaceutical research capabilities and opportunities

Organizer : ConferenceSeries.com hosts 3000+ Global Events that includes over 1000+ International Conferences, 1000+ Symposiums and 1000+Workshops and preconference workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management fields. Over 25 Million visitors flock to our websites to observe the attest developments in these fields.

Session/ Track:
• Drug Design and development: Challenges
• BA Studies and Assessment
• Drug Metabolism
• BE Studies and Assessment
• Pharmacology- PK & PD approach
• Pharmaceutical Dosage
• Clinical Research Vs Clinical Trails
• Biowaivers: Criteria
• BCS & IVIVC Based Biowaivers
• Biosimilars: Recent approches
• Drug Safety: Pharmaocovigilance Scope
• Contract Research Organizations
• Regulatory Requirements and Approaches
• Recent advancements in BA/BE Research
• Pharmaceutical Industry: Enterpreneur Meet